Adhesion molecule polymorphisms in chronic renal allograft failure

Kidney International

Volumn 55, Issue 5, 1999, Pages 1977-1982

  McLaren, Andrew J ^a,b   Marshall, Sara E ^a,b   Haldar, Neil A ^a,b   Mullighan, Charles G ^a,b   Fuggle, Susan V ^a,b   Morris, Peter J ^a,b   Welsh, Ken I ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

E469; Genetic risk factor; ICAM 1; Polymorphism; R241; Transplantation

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXON; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 0032917772     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00427.x     Document Type: Article

References (31)

1. 1. TILNEY N, WHITELY W, DIAMOND J, KUPIEC-WEGLINSKI J, ADAMS D: Chronic rejection: An undefined conundrum. Transplantation 52:389-398, 1991
2. 2. PAUL L, HAYRY P, FOEGH M-L, DENNIS MJ, MIHATSCH MJ, LARSSON E, FELLSTRÖM B: Diagnostic criteria of chronic rejection/accelerated graft atherosclerosis of heart and kidney transplants: Proposal from the fourth Alexis Carrel conference on chronic rejection and accelerated atherosclerosis in transplanted organs. Transplant Proc 25:2022-2023, 1993
3. 3. PAUL LC, HAYRY P, FOEGH M, FELLSTROM B: Chronic rejection and graft arteriosclerosis: 4 years after the Alexis Carrel proposal in diagnostic criteria. Transplant Proc 29:2628-2629, 1997
4. 4. HANCOCK WS, WHITLEY WD, TULLIUS SG, HEEMAN UW, WASOWSKA B, BALDWIN WM III, TILNEY NL: Cytokines, adhesion molecules and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 56:643-650, 1993
5. 5. NICHOLSON M, MCCULLOCH T, HARPER S, WHEATLEY T, EDWARDS C, FEEHALLY J, FURNESS PN: Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg 83:1082-1085, 1996
6. 6. SPRINGER T: Traffic signals on endothelium for lymphocyte recirculation and leucocyte emigration. (abstract) Annu Rev Physiol 57:827-872, 1995
7. 7. VAN SEVENTER G, SHIMUZU Y, HOGAN K, SHAW S: The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T-cell receptor-mediated activation of resting T cells. J Immunol 144:4579-4586, 1990
8. 8. TAKADA M, CHANDRAKER A, NADEAU K, SAYEGH M, TILNEY N: The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 100:1199-1203, 1997
9. 9. KASISKE B, KALIL R, LEE H, RAO K: Histopathologic findings associated with a chronic, progressive decline in renal allograft function. Kidney Int 40:514-524, 1991
10. 10. FUGGLE S, SANDERSON J, GRAY D, RICHARDSON A, MORRIS P: Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys: Correlation with intragraft events. Transplantation 55:117-123, 1993
11. 11. BROCKMEYER C, ULBRECHT M, SCHENDEL D, WEISS E, HILLEBRAND G, BURKHARDT K, LAND W, GOKEL MJ, REITHMÜLLER G: Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. Transplantation 55:610-615, 1993
12. 12. HILL P, MAIN I, ATKINS R: ICAM-1 and VCAM-1 in human renal allograft rejection. Kidney Int 47:1383-1391, 1995
13. 13. VON WILLEBRAND E, ISONIEMI J, HAYRY P, PAAVONEN T, KROGERUS L: Adhesion molecules and their ligands in chronic rejection of human renal allografts. Transplant Proc 29:1530-1531, 1997
14. 14. WENZEL K, ERNST M, ROHDE K, BAUMANN G, SPEER A: DNA polymorphisms in adhesion molecule genes: A new risk factor for early atherosclerosis. Hum Genet 97:15-20, 1996
15. 15. YANG H, VORA D, TARGAN S, TOYADA H, BEAUDET A, ROTTER J: Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 109:440-448, 1995
16. 16. VORA D, ROSENBLOOM C, BEAUDET A, COTTINGHAM R: Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 21:473-477, 1994
17. 17. YANG H, VORA D, TARGAN S, TOYODA H, BEAUDET AL, ROTTER JI: Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 109:440-448, 1995
18. 18. FERNANDEZ-REYES D, CRAIG A, KYES S, PESHU N, SNOW R, BERENDT A, MARSH K, NEWBOLD CI: A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 6:1357-1360, 1997
19. 19. BUNCE M, BARNARDO M, PROCTOR J, MARSH S, VILCHES C, WELSH K: High resolution HLA-C typing by PCR-SSP: Identification of allelic frequencies and linkage disequilibrium in 604 unrelated random UK caucasoids and a comparison with serology. Tissue Antigens 48:680-691, 1996
20. 20. BUNCE M, O'NEILL C, BARNARDO M, KRAUSA P, BROWNING M, MORRIS P, WELSH KI: Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 46:355-367, 1995
21. 21. DIAMOND M, STAUNTON D, MARLIN S, SPRINGER T: Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65:961-971, 1991
22. 22. DUPERRAY A, LANGUINO L, PLESCIA J, MCDOWALL A, HOGG N, CRAIG A, BERENDT AR ALTIERI DC: Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leucocyte-endothelium bridging. J Biol Chem 272:435-441, 1997
23. 23. SUGIMORO T, GRIFFITH D, ARNAOUT M: Emerging paradigms of integrin ligand binding and activation. Kidney Int 51:1454-1462, 1997
24. 24. FAULL R, KOVACH N, HARLAN J, GINSBERG M: Stimulation of integrin-mediated adhesion of T-lymphocytes and monocytes: Two mechanisms with divergent biological consequences. J Exp Med 179:1307-1316, 1994
25. 25. JOLING P, BOOM S, JOHNSON J, DEKKER M, VAN DEN TWEEL J, SCHUURMANN HJ, BLOEM AC: Domain 5 of the intercellular adhesion molecule-1 (ICAM-1) is involved in adhesion of B-cells and follicular dendritic cells. Adv Exp Med Biol 355:131-135, 1994
26. 26. FUGGLE S, KOO D: Cell adhesion molecules in clinical renal transplantation. Transplantation 65:763-769, 1998
27. 27. COSIMI A, CONTI D, DELMONICO F, PREFFER F, WEE S-L, ROTHLEIN R, FAANES R, COLVIN RB: In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 144:4604-4612, 1990
28. 28. HOURMANT M, BEDROSSIAN J, DURAND D, LEBRANCHU Y, RENOULT E, CAUDRELIER P, BUFFET R, SOULILLOU JP: A randomised multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplants. Transplantation 62:1565-1570, 1996
29. 29. HAUG C, COLVIN R, DELMONICO F, AUCHINCLOSS H, TOLKOFF-RUBIN N, PREFFER F, ROTHLEIN R, NORRIS S, SCHARSCHMIDT L, COSIMI AB: A phase 1 trial of immunosuppression with anti-icam-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766-773, 1993
30. 30. TAKADA M, NADEAU K, SHAW G, TILNEY N: Prevention of late renal changes after initial ischaemia/reperfusion injury by blocking early selectin binding. Transplantation 64:1520-1525, 1997
31. 31. ISOBE M, YAGITA H, OKUMURA K, IHARA A: Specific acceptance of Cardiac Allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125-1127, 1992